These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 16012463)

  • 41. Mice lacking tissue plasminogen activator and urokinase plasminogen activator genes show attenuated matrix metalloproteases activity after sciatic nerve crush.
    Siconolfi LB; Seeds NW
    J Neurosci Res; 2003 Nov; 74(3):430-4. PubMed ID: 14598319
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Remodeling of experimental arteriovenous fistula with increased matrix metalloproteinase expression in rats.
    Chan CY; Chen YS; Ma MC; Chen CF
    J Vasc Surg; 2007 Apr; 45(4):804-11. PubMed ID: 17398390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
    Schmalfeldt B; Prechtel D; Härting K; Späthe K; Rutke S; Konik E; Fridman R; Berger U; Schmitt M; Kuhn W; Lengyel E
    Clin Cancer Res; 2001 Aug; 7(8):2396-404. PubMed ID: 11489818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.
    Siefert SA; Chabasse C; Mukhopadhyay S; Hoofnagle MH; Strickland DK; Sarkar R; Antalis TM
    J Thromb Haemost; 2014 Oct; 12(10):1706-16. PubMed ID: 25041188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
    Leville CD; Dassow MS; Seabrook GR; Jean-Claude JM; Towne JB; Cambria RA
    J Surg Res; 2000 May; 90(2):183-90. PubMed ID: 10792961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA
    J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of the TNF-α (Tumor Necrosis Factor-α)-TNF-Rp55 (Tumor Necrosis Factor Receptor p55) Axis in the Resolution of Venous Thrombus.
    Nosaka M; Ishida Y; Kimura A; Kuninaka Y; Taruya A; Furuta M; Mukaida N; Kondo T
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2638-2650. PubMed ID: 30354252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression and localization of extracellular matrix-degrading proteinases and their inhibitors in the bovine mammary gland during development, function, and involution.
    Rabot A; Sinowatz F; Berisha B; Meyer HH; Schams D
    J Dairy Sci; 2007 Feb; 90(2):740-8. PubMed ID: 17235151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O; Ganster M; Baumgartner I; Nieselt K; Djonov V
    J Vasc Res; 2007; 44(3):202-13. PubMed ID: 17337906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2.
    Ottino P; Taheri F; Bazan HE
    Exp Eye Res; 2002 Mar; 74(3):393-402. PubMed ID: 12014920
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrin alphavbeta6 and mediators of extracellular matrix deposition are up-regulated in experimental biliary atresia.
    Nadler EP; Patterson D; Violette S; Weinreb P; Lewis M; Magid MS; Greco MA
    J Surg Res; 2009 Jun; 154(1):21-9. PubMed ID: 19084240
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
    Knappe UJ; Hagel C; Lisboa BW; Wilczak W; Lüdecke DK; Saeger W
    Acta Neuropathol; 2003 Nov; 106(5):471-8. PubMed ID: 12904990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel laminin 5 gamma 2-chain fragments potentiating the limbal epithelial cell outgrowth on amniotic membrane.
    Cheng CY; Sun CC; Yu WH; Hsieh HL; Ma DH; Pang JH; Yang CM
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4631-9. PubMed ID: 19420329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential expression of extracellular matrix components in the bovine oviduct during the oestrous cycle.
    Gabler C; Killian GJ; Einspanier R
    Reproduction; 2001 Jul; 122(1):121-30. PubMed ID: 11425336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms.
    Fontaine V; Jacob MP; Houard X; Rossignol P; Plissonnier D; Angles-Cano E; Michel JB
    Am J Pathol; 2002 Nov; 161(5):1701-10. PubMed ID: 12414517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin.
    Moaveni DK; Lynch EM; Luke C; Sood V; Upchurch GR; Wakefield TW; Henke PK
    J Vasc Surg; 2008 Mar; 47(3):616-24. PubMed ID: 18295113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Temporal expression and activation of matrix metalloproteinases-2, -9, and membrane type 1-matrix metalloproteinase following acute hindlimb ischemia.
    Muhs BE; Plitas G; Delgado Y; Ianus I; Shaw JP; Adelman MA; Lamparello P; Shamamian P; Gagne P
    J Surg Res; 2003 May; 111(1):8-15. PubMed ID: 12842442
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pre-Clinical Model to Study Recurrent Venous Thrombosis in the Inferior Vena Cava.
    Andraska EA; Luke CE; Elfline MA; Henke SP; Madapoosi SS; Metz AK; Hoinville ME; Wakefield TW; Henke PK; Diaz JA
    Thromb Haemost; 2018 Jun; 118(6):1048-1057. PubMed ID: 29695021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunohistochemical detection of uPA, tPA, and PAI-1 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation.
    Nosaka M; Ishida Y; Kuninaka Y; Kimura A; Kondo T
    Int J Legal Med; 2012 May; 126(3):421-5. PubMed ID: 22361951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.